ReportWire

Tag: Glioblastoma

  • Glioblastoma Foundation Launches Gliolab, Offering Three Cutting-Edge Genomic Tests to Deliver a Personalized Treatment Roadmap for Every Glioblastoma Patient

    [ad_1]

    On Glioblastoma Awareness Day, the Glioblastoma Foundation proudly announces the official launch of Gliolab, a CLIA-certified genomic testing laboratory dedicated exclusively to glioblastoma. Gliolab will offer three state-of-the-art genomic tests that together provide a personalized treatment roadmap for every patient diagnosed with this aggressive brain cancer, transforming care and access for thousands of families.

    In a healthcare environment where 77% of cancer genomic testing claims were denied by private insurers in 2024, the Foundation has made a bold and unprecedented commitment: every glioblastoma patient will have access to this essential testing, regardless of their insurance status.

    “This is a historic moment for the glioblastoma community,” said Dr. Gita Kwatra, PharmD, MBA, Co-founder and CEO of the Glioblastoma Foundation. “By launching Gliolab, we are changing the standard of care. Every glioblastoma patient deserves a treatment plan grounded in their tumor’s biology, not guesswork. Our genomic tests make that possible.”

    The three tests now available through Gliolab include:

    • Whole Genome DNA Methylation Profiling with Epignostix Classifier:
      This test uses DNA methylation patterns to precisely classify the tumor and identify copy number alterations, enabling more accurate diagnosis and prognosis.

    • Comprehensive Genomic Profiling using PGDx Elio™ Tissue Complete:
      A broad next-generation sequencing (NGS) test that analyzes over 500 cancer-related genes to detect mutations, copy number changes, microsatellite instability (MSI), and tumor mutational burden (TMB).

    • Gene Fusion Testing using Archer FusionPlex™ Pan Solid Tumor v2 Panel:
      This RNA-based test detects gene fusions and splicing variants that may be actionable or diagnostic in glioblastoma and other brain cancers.

    Together, these three tests provide clinicians and patients with a personalized treatment roadmap to guide therapeutic decisions, enrollment in clinical trials, and identification of novel treatment options.

    “As a neuro-oncologist who has treated glioblastoma patients for decades, I can say without hesitation: this kind of molecular insight is long overdue,” said Dr. Mark Gilbert, former Chief of the Neuro-Oncology Branch at the National Cancer Institute and advisor to the Glioblastoma Foundation. “The Foundation has done something extraordinary. Launching Gliolab and removing financial barriers to testing ensures that every patient-insured or not-gets the chance to receive optimal care.”

    Under the Foundation’s innovative three-tiered payment plan:

    • Patients with no insurance will receive free testing funded by philanthropy;

    • Patients with Medicare and private insurance will only be responsible for a co-pay.

    • The Foundation will be responsible for all other costs and claims.

    This model ensures equity of access while emphasizing that personalized treatment is not a luxury-it should be the standard of care.

    Physicians, hospitals, patients, and families seeking more information should contact the Foundation directly at info@glioblastomafoundation.org.

    About the Glioblastoma Foundation

    The Glioblastoma Foundation is a national nonprofit organization committed to transforming care for glioblastoma patients. Through genomic testing, translational research, drug development, and patient advocacy, the Glioblastoma Foundation works to improve outcomes and accelerate the path to a cure. To learn more please visit www.glioblastomafoundation.org.

    Contact Information:

    Ashley Pattman
    Media Outreach Coordinator
    info@glioblastomafoundation.org
    919-402-1775

    Source: Glioblastoma Foundation

    [ad_2]

    Source link

  • Glioblastoma Foundation Genomic Testing & Research Laboratory Ribbon-Cutting Ceremony on Sept. 3rd

    Glioblastoma Foundation Genomic Testing & Research Laboratory Ribbon-Cutting Ceremony on Sept. 3rd

    [ad_1]

    Opening of testing lab ushers in a new era of targeted treatments to change glioblastoma diagnosis from terminal to treatable

    The Glioblastoma Foundation is hosting a welcome ceremony to inaugurate its innovative Genomic Testing & Research Laboratory, a first-of-its-kind lab in the U.S. The cutting-edge laboratory is set to revolutionize the fight against glioblastoma by offering patients access to advanced genomic testing and personalized drug identification. Attendees will have a first-hand opportunity to tour the state-of-the-art lab, meet the team behind this groundbreaking initiative, and learn about the future of tailored glioblastoma treatment. The Lab aims to provide crucial, low-cost testing services and faster turnaround to enhance outcomes and improve quality of life for glioblastoma patients.

    WHAT: To mark the opening of the Genomic Testing & Research Laboratory, the Glioblastoma Foundation is hosting informational speakers and a guided tour of the Lab and testing equipment.

    WHO: Oncologists, neurologists, researchers, patients and their families, the media, and anyone else interested in leading the fight against the most aggressive form of brain cancer are welcome.

    WHERE: The Chesterfield Building, 701 W. Main St., Suite 200, Durham, NC 27701

    WHEN: Tuesday, September 3, 2024; 10:00 AM – 2:00 PM

    Scheduled activities

    10:00 AM – 10:15 AM  Registration & Refreshments

    10:15 AM – 10:30 AM   Welcoming Remarks, Gita Kwatra, PharmD, MBA CEO, Glioblastoma Foundation, Durham, NC 

    10:35 AM  – 10:55 PM  Glioblastoma Diagnosis & Surgery, Christopher Jackson, MD, Assistant Professor, Dept of Neurosurgery Johns Hopkins University, Baltimore, MD 

    11:00 AM – 11:20 AM   Postsurgical Management of Glioblastoma Patients, Glenn Lesser, MD, Professor & Deputy Director, Atrium Health Wake Forest Baptist, Comprehensive Cancer Center Wake Forest University Medical Center, Winston-Salem, NC

    11:25 AM – 11:45 AM   Mission of the Personalized Medicine Coalition (PMC), Christopher Wells, MPA, Senior Vice President for Public Affairs, PMC, Washington, DC  

    11:50 AM – 12:00 PM   Ribbon-Cutting Ceremony  

    12:00 PM – 1:00 PM     Catered Lunch 

    1:00 PM – 2:00 PM       Guided Lab Tours        

    DETAILS: RSVP By August 29, 2024, to Sydney Carmer at sydney@glioblastomafoundation.org

    For more information about the Glioblastoma Foundation, visit https://glioblastomafoundation.org/

    ###

    About the Glioblastoma Foundation: Established in 2016, the Glioblastoma Foundation aims to transform glioblastoma treatment and care through research, advocacy, and support initiatives. By funding innovative research projects, raising awareness, and providing resources for patients and families, the Foundation strives to improve outcomes and quality of life for those affected by this aggressive form of brain cancer. Initiatives such as the Genomic Testing & Research Laboratory will allow the Foundation to transform glioblastoma from a terminal cancer to a treatable one within the next five years. For more information about the Glioblastoma Foundation, please visit https://www.glioblastomafoundation.org.

    Source: Glioblastoma Foundation, Inc.

    [ad_2]

    Source link

  • Medical Marijuana May Help With Brain Cancer

    Medical Marijuana May Help With Brain Cancer

    [ad_1]

    Brain cancer has been in the news – it is a devastating diagnosis, but there is hope cannabis could help.

    Michael Strahan has gone public with one of his daughters has brain cancer. Since then, she is having a slow recovery she is sharing to bring awareness brain cancer is an all age disease. Over 100,000 people are diagnosed with a primary brain tumor annually. Brain and other CNS tumors are the fifth most common cancer. Over 30,000 children are currently diagnosed with a brain tumor. Over 1 million people are living with a diagnosis of a primary brain tumor and it can be a rough road. Early research suggest medical marijuana may help with brain cancer.

    RELATED: Science Says Medical Marijuana Improves Quality Of Life

    It is proven cannabis has medical benefits, but more research needs to be done to better define how it can have an impact and help patients. Currently, the evidence that cannabis-based products can treat brain tumours or brain cancer is limited. Preliminary studies from the lab suggest that cannabinoid chemicals THC and CBD can stop glioblastoma (GBM) cells from growing, causing them to die and disrupting the blood supply to the tumour cells.

    Photo by pilli/Getty Images

    There has been some data and research around glioma which looks promising. Glioma is a growth of cells that starts in the brain or spinal cord. The cells in a glioma look similar to healthy brain cells called glial cells. Glial cells surround nerve cells and help them function. As a glioma grows it forms a tumor.

    Preliminary studies from the lab suggest that cannabinoid chemicals THC and CBD can stop glioblastoma (GBM) cells from growing, causing them to die and disrupting the blood supply to the tumour cells.

    In 2021, an early-stage trial led by Professor Susan Short suggested that adding a specific blend of these chemicals – in the form of a drug called Sativex – to chemotherapy could potentially help treat recurrent GBMs more effectively.

    RELATED: The Most Popular Marijuana Flavors

    CXannabis-based drug Sativex approved as a prescription medicine. The drug, used in treating multiple sclerosis, was also found to be tolerable in combination with chemotherapy, with the potential to extend survival, in a phase I trial in glioblastomas.

    A phase II trial, led by the University of Leeds, is assessing whether adding Sativex – an oral spray containing cannabinoids THC and CBD – to chemotherapy, could extend life for thousands diagnosed with a recurrent glioblastoma. Currently, it has an average survival of less than 10 months.

    Scientific research indicates medical cannabis and cannabinoids could become key therapy in modern neuro-oncology; however, further studies are needed to establish outcomes and  dosage.

    [ad_2]

    Sarah Johns

    Source link

  • Glioblastoma Foundation Hosts ‘Rock Against Glioblastoma’ (RAG), Shining a Spotlight on Deadliest Form of Brain Cancer

    Glioblastoma Foundation Hosts ‘Rock Against Glioblastoma’ (RAG), Shining a Spotlight on Deadliest Form of Brain Cancer

    [ad_1]

    First Annual Music Festival Features Talented Lineup of Performers at the Legendary Cat’s Cradle, Raising Vital Funds for Glioblastoma Research & Treatment

    The Glioblastoma Foundation (https://glioblastomafoundation.org/) is excited to announce its inaugural Rock Against Glioblastoma ™ (RAG) music festival – raising awareness of Glioblastoma, a highly aggressive terminal stage 4 brain cancer, as well as critical funds for the development of new and more effective treatments. It is a heartfelt tribute to the memory of the late drummer Sara Romweber, who lost her battle with the disease in 2019. Glioblastoma also claimed the life of renowned Rush drummer Neil Peart in 2020.

    Rock Against Glioblastoma (RAG) takes place December 2nd at the historic Cat’s Cradle in Chapel Hill, NC, featuring an incredible lineup of well-known performers. Doors open at 6:30 p.m. EST, with performances by The Popes, What Peggy Wants, Bad Checks, Snatches of Pink, and Sara’s brother Dex Romweber. Tickets are available at the door and online for $20.

    Funds raised during this event will be used to advance critical glioblastoma drug development and other new treatments for patients. Monies will also go towards continuing ongoing research on repurposing existing drug therapies for glioblastoma and developing a blood test for early detection of glioblastoma.

    Glioblastoma Foundation CEO Gita Kwatra stated, “We believe that no one should hear the word ‘glioblastoma’ for the first time upon their own diagnosis. Our mission is to educate, connect, and involve the public in understanding glioblastoma well before it affects them or their loved ones. We’re eager to bring more awareness to this issue through the music community, who have already lost so many due to the disease.”

    For more information about the Rock Against Glioblastoma (RAG) music festival, sponsorship opportunities, or to purchase tickets, please visit the Glioblastoma Foundation website at https://glioblastomafoundation.org/get-involved/rock-against-glioblastoma-music-festival

    About the Glioblastoma Foundation:

    The Glioblastoma Foundation is a national non-profit organization dedicated to improving the standard of care for glioblastoma patients. The organization funds innovative research, provides patient and family support and education, and advocates for policies that expedite the development of improved treatments. Learn more at https://glioblastomafoundation.org/.

    ###

    Media Contact:

    Rita Tennyson

    rita.tennyson@orcapr.com

    310-779-9747

    Debbie Koke

    debbie.koke@orcapr.com

    914-536-7557

    Source: Glioblastoma Foundation

    [ad_2]

    Source link

  • The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma

    The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma

    [ad_1]

    The Glioblastoma Foundation® launched a new awareness campaign today featuring Morgan Myles as the celebrity ambassador with the goal of raising awareness of Glioblastoma — the most lethal and common form of brain cancer.

    Press Release



    updated: Feb 23, 2023

    Morgan Myles was a top three finalist on the latest season of NBC’s The Voice, and now she is hopeful to use her voice in a different way — to share her family’s story and bring more awareness to the work that the Glioblastoma Foundation is doing to assist patients in their fight against this aggressive cancer.

    While on The Voice, Myles dedicated her semi-final performance of Lady Gaga’s “Remember Us This Way” in memory of her cousin Mac and her grandfather — both of whom she tragically lost to Glioblastoma.

    “It was a deeply felt loss for my family,” said Myles. “Mac was so young, with so much life to live. I wanted to stay strong for Mac and my family and stay hopeful.

    “I channeled everything I was going through with losing Mac into my music. I’m proud to use my platform to bring increased awareness to Glioblastoma and the work of the Glioblastoma Foundation.”

    Myles is featured in a digital campaign highlighting the urgent need for funding to support the development of new, more effective treatments to help Glioblastoma patients live longer and more comfortably. 

    Glioblastoma is the most common and most deadly form of brain cancer, with an overall five-year survival rate of just 5 percent. Each year, over 15,000 people are diagnosed with Glioblastoma and half of those diagnosed pass away within one year.  

    While Glioblastoma has received more attention in recent years due to the introduction of Glioblastoma Awareness Day in 2019 — more public education and research funding is desperately needed.  

    “We are so grateful to Morgan for sharing her story with us, and for her efforts to bring more awareness and urgency to this deadly disease, for which we desperately need increased funding for new, more effective treatments,” said Gita Kwatra, PharmD, MBA, and CEO of the Glioblastoma Foundation.  

    “The current standard of care for Glioblastoma falls short. Every dollar donated to the Glioblastoma Foundation can make a difference and help fund essential research that will lead to better treatment options and, ultimately, a cure,” explained Gita.

    To learn more about the Glioblastoma Foundation’s research initiatives and how you can get involved, visit https://glioblastomafoundation.org and follow the Glioblastoma Foundation on Facebook, Instagram, Twitter, and YouTube. Email info@glioblastomafoundation.org for additional information.

    Source: Glioblastoma Foundation

    [ad_2]

    Source link

  • I’m 44 And Only Have Months To Live. Here’s What I Want My Kids To Know About Life.

    I’m 44 And Only Have Months To Live. Here’s What I Want My Kids To Know About Life.

    [ad_1]

    I have months to live, perhaps two, perhaps some other number, the doctors won’t tell me. They can’t. They do not know. Instead, they talk about “response to treatment,” clinical trials, science with an aperture of hope.

    Some days hope feels puerile and unproductive, unmatched by the reality of this brain tumor, which formed in my left parietal lobe, expanded to my cerebellum, and is currently spreading down my spine. It is a base and primal thing, unaware, or unconcerned, that it is draining my capacity to remember names and places, follow recipes, descend an unrailed staircase, walk in a straight line ― that it will kill me.

    Forty-four feels horribly young for a terminal diagnosis in an otherwise healthy, active body, and for glioblastoma, in particular, the cancer of Ted Kennedy and John McCain, old men in the sunset of life. It has been a long time since I have been considered young in a medical capacity ― me of the “geriatric” pregnancies. But here I am, young and old, losing my life minute by minute and my memory even faster.

    In many ways, over many years, I have trained myself to forget the present as it occurs, or not let it register in the first place. This began in fifth grade ― the year my dad departed under the guise of temporary separation, taking the necessary steps to launch his academic career in California.

    My brothers, sister and I slowly woke to the fact that we would never again all live under the same roof. We stayed put in Ithaca, the place my dad had uprooted us to in pursuit of that critical, door-opening, life-altering Ph.D. With the pursuit over, the objective achieved, he was off and I was stranded in the same split-level house we had helped scrub the pet stench from three years earlier. “Don’t worry, this is temporary,” my dad had promised 7-year-old me. For him, yes, but I lived there until the summer before I left for college.

    I learned to live outside my body ― or perhaps deep within it ― willing myself inaccessible, unmoved. The summer before high school, I lived with my dad. Left to my own devices, I explored the woods and set off on runs along busy roads. Ordering my head steady, my eyes dry, I pretended not to wince at the catcalls or startle at the car horns from men who tried to get my attention.

    I cultivated detachment as a skill ― a shield against pain, discomfort, exposure ― muting even the sound of my own name yelled down a hallway. “I called to you after fifth period, but you didn’t even look up,” my sister exclaimed. I had no recollection of it. I was pulled too tightly into myself, closed off, shut down, unable to decipher what exactly the world thought I offered and to whom.

    “I cultivated detachment as a skill ― a shield against pain, discomfort, exposure ― muting even the sound of my own name yelled down a hallway.”

    This separation continued, driven by habit, not desire. I remember stumbling upon a late-night study group on a Saturday night in college. Surprised by the interruption but unconcerned, their focus already extended deep and wide as they raised new questions, consulted additional texts, rubbed their temples, shrugged, laughed. I remember wishing I could stay there with them and just listen to what they said in the night. Instead, I lurched back outside, toward the noise, the sticky floors and plastic cups of fraternity basements, the sense that I was a walking shadow, putting one foot in front of the other without desire or destination.

    I spent another decade feeling divided and incomplete within myself without making any significant changes to remedy that. In my early 30s, I moved to Florida to run an office transition, despite wanting to stay in New York and change careers. Isolated and adrift, I played the part of competent manager during the day, while at night I lay awake wondering how I had gotten so off track. I drank to excess and was pulled over for erratic driving. I thought this would undo me; instead, it forced me to confront and rebuild.

    I joined women’s groups and built critical friendships. I learned to tell the truth about who I am and what I need. I switched jobs, then careers. I stopped believing there was something fundamentally broken inside me that could not be fixed.

    I settled in Brooklyn. I married the man I had fallen in love with years earlier when celebrating my 25th birthday at an Irish pub in Manhattan. I learned to give honest answers to essential questions, such as, “How are you?” “What are you thinking?” “How can I help?” I gave birth to two children who fill my life with joy and love I never let myself hope to have. We built a family.

    And then, last December, I lost the ability to write. I showed my husband my spelling errors and nonsensical scribble on our holiday cards. “I don’t know what’s happening to me,” I sobbed. The next day in the ER, we learned I had a mass in my brain. It took another two months to learn the diagnosis of glioblastoma; longer still to understand just how powerful and unrelenting these tumors are ― mine no exception. Suddenly, this body that once ran marathons and traveled the world could no longer be trusted to carry my daughter into school in the morning or up the stairs to bed.

    Now, we are told I may have just months to live. It is devastating in so many ways. There are so many things I still want to do ― hike Mount Kilimanjaro, speak fluent French; so many things I thought I would be ― a novelist, a grandmother. So many of life’s moments ― First Communions, sleepaway camps, travels abroad ― I thought I’d prepare my children for and help usher them through. But I can’t. Not with any certainty.

    Yet, I accept the terms because it means I get to be here with them ― my beautiful family ― a little bit longer. I get to be with them in the world. I get to be alive in the world.

    And that is what I have finally internalized ― the incredible gift of this life’s journey, and the ability to be fully present within it, living, loving, hurting, grieving, discovering. Being. Because even though life can be hard and cruel and painful, it is still incredible. And we get to experience it. We get to live it. We get to be in the middle of it. Yes, it often takes something profoundly difficult, something life-altering, to see this clearly, but what a thing to see and to know for sure.

    “Even though life can be hard and cruel and painful, it is still incredible. And we get to experience it. We get to live it. We get to be in the middle of it.”

    I will continue to wish for the nearly impossible ― a cure, a breakthrough, a decade ― but plan for and prepare my children for the increasingly inevitable ― the loss of me. I will live with an eye toward what is next ― for them, for all of us ― and ensure I embody the lessons I hope they will carry within them.

    What I hope for them ― what I wish to convey to them and want anyone reading this to consider ― is this: cultivate the courage and ability to be fully present in your life, the joy and the pain. Let the hurt and disappointment ― even rage ― of my decline and death and all of life’s heartbreaks and struggles strengthen you and open you up, rather than shut you down. Gravitate toward connection over isolation. Find those lit rooms of earnest conversation in the night. Explore your evolving truths about who you are and what you want and what you need. Don’t let decades pass only to realize you haven’t been fully present and you don’t remember who you have touched or loved. Look up when someone calls your name.

    Elizabeth King is a mom and former educator living with glioblastoma.

    Do you have a compelling personal story you’d like to see published on HuffPost? Find out what we’re looking for here and send us a pitch.

    [ad_2]

    Source link